Intuitive Surgical, Inc. (0R29.L)
USD 508.51
(3.02%)
USD 508.51
(3.02%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -2.66 Billion USD | -78.86% |
| 2022 | -1.48 Billion USD | -23.55% |
| 2021 | -1.2 Billion USD | 21.96% |
| 2020 | -1.54 Billion USD | -41.38% |
| 2019 | -1.09 Billion USD | 77.43% |
| 2018 | -4.83 Billion USD | -25.68% |
| 2017 | -3.84 Billion USD | 20.49% |
| 2016 | -4.83 Billion USD | -44.51% |
| 2015 | -3.34 Billion USD | -34.07% |
| 2014 | -2.49 Billion USD | -219.27% |
| 2013 | -782.1 Million USD | 73.22% |
| 2012 | -2.92 Billion USD | -34.47% |
| 2011 | -2.17 Billion USD | -34.99% |
| 2010 | -1.6 Billion USD | -37.28% |
| 2009 | -1.17 Billion USD | -502.18% |
| 2008 | -194.62 Million USD | -58.46% |
| 2007 | -122.82 Million USD | -257.15% |
| 2006 | -34.39 Million USD | -524.36% |
| 2005 | -5.5 Million USD | -6.7% |
| 2004 | -5.16 Million USD | 46.29% |
| 2003 | -9.61 Million USD | 32.6% |
| 2002 | -14.25 Million USD | -76.35% |
| 2001 | -8.08 Million USD | 56.94% |
| 2000 | -18.77 Million USD | -57000.0% |
| 1999 | 33 Thousand USD | -98.65% |
| 1998 | 2.43 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -2.83 Billion USD | -6.74% |
| 2024 Q2 | -3.03 Billion USD | -6.94% |
| 2024 Q3 | -2.41 Billion USD | 20.53% |
| 2023 Q3 | -3.6 Billion USD | -4.85% |
| 2023 FY | -2.66 Billion USD | -78.86% |
| 2023 Q1 | -371.4 Million USD | 75.03% |
| 2023 Q2 | -3.43 Billion USD | -824.99% |
| 2023 Q4 | -2.66 Billion USD | 26.14% |
| 2022 Q3 | -1.53 Billion USD | -0.12% |
| 2022 Q2 | -1.53 Billion USD | -39.25% |
| 2022 Q1 | -1.1 Billion USD | 8.37% |
| 2022 FY | -1.48 Billion USD | -23.55% |
| 2022 Q4 | -1.48 Billion USD | 3.29% |
| 2021 Q2 | -1.61 Billion USD | -15.24% |
| 2021 Q3 | -1.34 Billion USD | 16.64% |
| 2021 Q4 | -1.2 Billion USD | 10.6% |
| 2021 FY | -1.2 Billion USD | 21.96% |
| 2021 Q1 | -1.4 Billion USD | 10.41% |
| 2020 Q3 | -1.09 Billion USD | 46.21% |
| 2020 Q1 | -1.22 Billion USD | -4.81% |
| 2020 FY | -1.54 Billion USD | -41.38% |
| 2020 Q2 | -2.03 Billion USD | -66.33% |
| 2020 Q4 | -1.56 Billion USD | -42.9% |
| 2019 Q4 | -1.16 Billion USD | -30.11% |
| 2019 Q2 | -5.07 Billion USD | -1.71% |
| 2019 Q3 | -897.4 Million USD | 82.33% |
| 2019 Q1 | -4.99 Billion USD | -482.04% |
| 2019 FY | -1.09 Billion USD | 77.43% |
| 2018 Q1 | -4.06 Billion USD | -5.76% |
| 2018 FY | -4.83 Billion USD | -25.68% |
| 2018 Q4 | -857.9 Million USD | 81.23% |
| 2018 Q3 | -4.57 Billion USD | -7.3% |
| 2018 Q2 | -4.25 Billion USD | -4.7% |
| 2017 FY | -3.84 Billion USD | 20.49% |
| 2017 Q3 | -3.8 Billion USD | -11.06% |
| 2017 Q2 | -3.42 Billion USD | -8.79% |
| 2017 Q1 | -3.14 Billion USD | 34.96% |
| 2017 Q4 | -3.84 Billion USD | -1.17% |
| 2016 Q3 | -4.56 Billion USD | -7.96% |
| 2016 FY | -4.83 Billion USD | -44.51% |
| 2016 Q1 | -980.5 Million USD | 70.71% |
| 2016 Q4 | -4.83 Billion USD | -6.06% |
| 2016 Q2 | -4.22 Billion USD | -330.89% |
| 2015 Q3 | -3.12 Billion USD | -8.95% |
| 2015 Q1 | -2.66 Billion USD | -344.28% |
| 2015 Q2 | -2.86 Billion USD | -7.56% |
| 2015 Q4 | -3.34 Billion USD | -7.12% |
| 2015 FY | -3.34 Billion USD | -34.07% |
| 2014 Q2 | -2.04 Billion USD | -151.03% |
| 2014 Q1 | -814 Million USD | -4.08% |
| 2014 Q3 | -2.26 Billion USD | -10.73% |
| 2014 Q4 | -600.3 Million USD | 73.47% |
| 2014 FY | -2.49 Billion USD | -219.27% |
| 2013 Q1 | -3.11 Billion USD | -6.69% |
| 2013 Q4 | -782.1 Million USD | 69.12% |
| 2013 FY | -782.1 Million USD | 73.22% |
| 2013 Q2 | -3.02 Billion USD | 2.85% |
| 2013 Q3 | -2.53 Billion USD | 16.35% |
| 2012 FY | -2.92 Billion USD | -34.47% |
| 2012 Q3 | -396.2 Million USD | 84.94% |
| 2012 Q4 | -2.92 Billion USD | -637.13% |
| 2012 Q1 | -2.37 Billion USD | -409.02% |
| 2012 Q2 | -2.63 Billion USD | -10.97% |
| 2011 FY | -2.17 Billion USD | -34.99% |
| 2011 Q3 | -1.88 Billion USD | -3.58% |
| 2011 Q2 | -1.82 Billion USD | -305.07% |
| 2011 Q1 | -449.8 Million USD | -60.76% |
| 2011 Q4 | -465.8 Million USD | 75.32% |
| 2010 Q3 | -1.62 Billion USD | -2.04% |
| 2010 Q2 | -1.58 Billion USD | -13.81% |
| 2010 Q4 | -279.8 Million USD | 82.73% |
| 2010 Q1 | -1.39 Billion USD | -530.2% |
| 2010 FY | -1.6 Billion USD | -37.28% |
| 2009 FY | -1.17 Billion USD | -502.18% |
| 2009 Q2 | -902.06 Million USD | -833.76% |
| 2009 Q3 | -1.02 Billion USD | -13.52% |
| 2009 Q4 | -221.43 Million USD | 78.37% |
| 2009 Q1 | -96.6 Million USD | 50.36% |
| 2008 Q3 | -227.61 Million USD | -2.06% |
| 2008 Q1 | -230.8 Million USD | -87.92% |
| 2008 Q2 | -223.02 Million USD | 3.37% |
| 2008 Q4 | -194.62 Million USD | 14.49% |
| 2008 FY | -194.62 Million USD | -58.46% |
| 2007 Q3 | -86.39 Million USD | -31.47% |
| 2007 Q2 | -65.71 Million USD | -27.96% |
| 2007 Q1 | -51.35 Million USD | -49.33% |
| 2007 Q4 | -122.82 Million USD | -42.17% |
| 2007 FY | -122.82 Million USD | -257.15% |
| 2006 Q1 | -5.21 Million USD | -15.71% |
| 2006 FY | -34.39 Million USD | -524.36% |
| 2006 Q4 | -34.39 Million USD | 35.65% |
| 2006 Q3 | -53.44 Million USD | -72.06% |
| 2006 Q2 | -31.06 Million USD | -495.49% |
| 2005 FY | -5.5 Million USD | -6.7% |
| 2005 Q4 | -4.5 Million USD | 48.15% |
| 2005 Q3 | -8.69 Million USD | -11.45% |
| 2005 Q2 | -7.8 Million USD | 26.94% |
| 2005 Q1 | -10.67 Million USD | -106.86% |
| 2004 Q2 | -7.09 Million USD | 40.43% |
| 2004 Q3 | -10.4 Million USD | -46.6% |
| 2004 Q1 | -11.91 Million USD | -23.96% |
| 2004 Q4 | -5.16 Million USD | 50.38% |
| 2004 FY | -5.16 Million USD | 46.29% |
| 2003 FY | -9.61 Million USD | 32.6% |
| 2003 Q4 | -9.61 Million USD | 7.35% |
| 2003 Q3 | -10.37 Million USD | 31.77% |
| 2003 Q2 | -15.2 Million USD | 23.26% |
| 2003 Q1 | -19.8 Million USD | -38.93% |
| 2002 FY | -14.25 Million USD | -76.35% |
| 2002 Q3 | -15.16 Million USD | 30.7% |
| 2002 Q2 | -21.87 Million USD | -300.27% |
| 2002 Q1 | -5.46 Million USD | 32.39% |
| 2002 Q4 | -14.25 Million USD | 5.96% |
| 2001 Q2 | -20.6 Million USD | -103.48% |
| 2001 Q1 | -10.12 Million USD | 46.08% |
| 2001 FY | -8.08 Million USD | 56.94% |
| 2001 Q3 | -21.75 Million USD | -5.59% |
| 2001 Q4 | -8.08 Million USD | 62.83% |
| 2000 Q1 | -34.79 Million USD | 0.0% |
| 2000 FY | -18.77 Million USD | -57000.0% |
| 2000 Q3 | -22.78 Million USD | 37.92% |
| 2000 Q2 | -36.7 Million USD | -5.48% |
| 2000 Q4 | -18.77 Million USD | 17.58% |
| 1999 FY | 33 Thousand USD | -98.65% |
| 1998 FY | 2.43 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Phreesia, Inc. | -75.53 Million USD | -3421.85% |
| Accuray Incorporated | 103.58 Million USD | 2668.204% |
| Align Technology, Inc. | -840.47 Million USD | -216.525% |
| Elevance Health Inc. | 18.59 Billion USD | 114.307% |
| AxoGen, Inc. | 32.26 Million USD | 8344.902% |
| Boston Scientific Corporation | 8.23 Billion USD | 132.317% |
| CVS Health Corporation | 71.18 Billion USD | 103.737% |
| Cardinal Health, Inc. | 476 Million USD | 658.887% |
| Centene Corporation | 506 Million USD | 625.751% |
| DaVita Inc. | 10.65 Billion USD | 124.975% |
| HCA Healthcare, Inc. | 40.92 Billion USD | 106.501% |
| Hologic, Inc. | 374.4 Million USD | 810.55% |
| Humana Inc. | 5.51 Billion USD | 148.203% |
| IDEXX Laboratories, Inc. | 493.94 Million USD | 638.579% |
| Laboratory Corporation of America Holdings | 5.41 Billion USD | 149.107% |
| Masimo Corporation | 804 Million USD | 430.883% |
| McKesson Corporation | 889 Million USD | 399.246% |
| Patterson Companies, Inc. | 648.47 Million USD | 510.238% |
| Quest Diagnostics Incorporated | 4.68 Billion USD | 156.808% |
| ResMed Inc. | 635.57 Million USD | 518.567% |
| Henry Schein, Inc. | 2.57 Billion USD | 203.514% |
| Teladoc Health, Inc. | 468.6 Million USD | 667.71% |
| Universal Health Services, Inc. | 5.24 Billion USD | 150.7% |
| Veeva Systems Inc. | -647.71 Million USD | -310.723% |
| Baxter International Inc. | 11.16 Billion USD | 123.825% |
| Becton, Dickinson and Company | 14.46 Billion USD | 118.394% |
| Danaher Corporation | 13.49 Billion USD | 119.718% |
| Stryker Corporation | 10.02 Billion USD | 126.539% |
| Medtronic plc | 23.67 Billion USD | 111.235% |